Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Trading Down 3.3% – Should You Sell?

Shares of Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) fell 3.3% during mid-day trading on Thursday . The company traded as low as $58.00 and last traded at $58.00. Approximately 100 shares traded hands during trading, a decline of 36% from the average daily volume of 157 shares. The stock had previously closed at $60.00.

Recordati Industria Chimica E Farmaceutica Trading Down 3.3%

The firm has a 50-day simple moving average of $57.72 and a 200-day simple moving average of $60.93. The company has a quick ratio of 1.16, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The stock has a market cap of $11.97 billion, a PE ratio of 21.94 and a beta of 0.25.

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) last announced its quarterly earnings results on Wednesday, May 13th. The company reported $1.08 earnings per share for the quarter. The company had revenue of $834.86 million during the quarter. Recordati Industria Chimica E Farmaceutica had a return on equity of 34.38% and a net margin of 17.81%.

Recordati Industria Chimica E Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica is an Italy‐based international pharmaceutical company engaged in the research, development, manufacturing and commercialization of therapeutic products. Established in 1926, the company has built a diversified portfolio that includes proprietary drugs, generics and orphan medicines, with a particular emphasis on treatments for rare diseases. Recordati’s product range spans cardiovascular, urology, endocrinology, dermatology and oncology therapies, as well as specialized formulations for genetic and metabolic disorders.

The company’s historical roots date back nearly a century, when it began as a family‐owned enterprise in Milan.